We also found that progression-free survival (PFS) could be predicted in all glioma patients by LIGHT expression, where high LIGHT expression indicated a shorter PFS (Figure S2A, P < 0.0001), meaning high LIGHT expression might be associated with more rapid progression. This evidence concerns the gene TNFSF14 and central nervous system cancer.